Treatment outcomes in glioblastoma patients aged 76 years or older: a multicenter retrospective cohort study
Takamasa Kayama(Yamagata University), Kaori Sakurada(Miyoshi Kasei (Japan)), Kuniaki Ogasawara(Iwate Medical University), Masahiro Ichikawa(Fukushima Medical University), Hiroshi Aoki(Nippon Veterinary and Life Science University), Chifumi Kitanaka(Yamagata University), Kenichiro Asano(Hirosaki University), Takeo Uzuka(Hirosaki University), Hiroki Ohkuma(Hirosaki National Hospital), Yukihiko Fujii(Niigata University), Toshihiro Kumabe(Kitasato University), Teiji Tominaga(Tohoku University), Kiyoshi Saito(Waseda University), Toshio Sasajima(Iwate Medical University), Takaaki Beppu(Iwate Medical University), Kazuo Mizoi(Tohoku University)
Cited by 18
Related Papers
Guidelines for the use and interpretation of assays for monitoring autophagy
|Autophagy|2012|4.1k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in Medulloblastoma
|Journal of Clinical Oncology|2013|488
The Tohoku Medical Megabank Project: Design and Mission
|Journal of Epidemiology|2016|386